Rezolute, Inc.
Crystalline forms of plasma kallikrein inhibitors
Last updated:
Abstract:
Pure crystalline forms of 1-benzyl-N-(4-carbamimidoylbenzyl)-1H-pyrazole-4-carboxamide acetate, and an amorphous form, pharmaceutical compositions thereof, and methods for making the same, are disclosed. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
7 Jul 2020
Issue date:
19 Apr 2022